🕵️ Ensysce Biosciences, Inc. ($ENSCW)
SEC insider & ownership activity, last 12 months · CIK 1716947 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), May 22, 2026.
Insider flow
1 buyer, value withheld pending verification (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Bob G. Gower | 2 | value withheld pending verification | 0 | – | Aug 7, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bob Gene Gower | 6.1% | 13D | Aug 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Aug 25, 2026 | filing ↗ |
| Other events (8.01) | Aug 24, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 5, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Aug 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 5, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Aug 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 15, 2026 | filing ↗ |
| Delisting notice (3.01) | May 22, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 7, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |